Cargando…

Comparison of Clinical and Radiological Features of Aquaporin4 (AQP-4) Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) and Anti Myelin Oligodendrocyte Glycoprotein (Anti-MOG) Syndrome-Our Experience from Northwest India

BACKGROUND: More and more cases of myelin oligodendrocyte glycoprotein (MOG) antibody are being diagnosed with the availability of laboratory tests helping us to know the differing patterns from AQP-4 antibody disease and we need to understand the natural course, treatment, and prognosis in a better...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Rajendra Singh, Jain, Deepak, Murarka, Sourabh, Vyas, Arvind, Sharma, Bhawna, Srivastava, Trilochan, Kumar, Kamlesh, Jain, Yavnika, Rao, Kavya, Agrawal, Jitesh, Tejwani, Shankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175426/
https://www.ncbi.nlm.nih.gov/pubmed/35693673
http://dx.doi.org/10.4103/aian.aian_860_21
_version_ 1784722455068147712
author Jain, Rajendra Singh
Jain, Deepak
Murarka, Sourabh
Vyas, Arvind
Sharma, Bhawna
Srivastava, Trilochan
Kumar, Kamlesh
Jain, Yavnika
Rao, Kavya
Agrawal, Jitesh
Tejwani, Shankar
author_facet Jain, Rajendra Singh
Jain, Deepak
Murarka, Sourabh
Vyas, Arvind
Sharma, Bhawna
Srivastava, Trilochan
Kumar, Kamlesh
Jain, Yavnika
Rao, Kavya
Agrawal, Jitesh
Tejwani, Shankar
author_sort Jain, Rajendra Singh
collection PubMed
description BACKGROUND: More and more cases of myelin oligodendrocyte glycoprotein (MOG) antibody are being diagnosed with the availability of laboratory tests helping us to know the differing patterns from AQP-4 antibody disease and we need to understand the natural course, treatment, and prognosis in a better way. OBJECTIVES: Neuromyelitis optica spectrum disorder (NMOSD) and anti-MOG syndromes are immune-mediated inflammatory demyelinating conditions of the central nervous system (CNS) that mainly involve the optic nerves and the spinal cord. We conducted this study to compare demographic, clinical, laboratory, and radiological features of AQP-4 antibody and MOG antibody positive patients. METHODS: A single-centre retrospective observational study from a large tertiary care university centre of Northwest India conducted during 2019--2021. We screened all patients presenting with acute CNS demyelinating attacks and recruited total 47 patients of which 25 were positive for AQP4 antibody and 22 were positive for MOG antibody. No patient tested positive for both antibodies. Data were collected using a standardized format including demographic, clinical, laboratory, and neuroimaging data. RESULTS: In our study, total 47 patients were included, amongst which 25 patients were AQP4 antibody and 22 patients were MOG antibody positive. Though there was no gender preponderance, pediatric patients were more frequently affected in MOG antibody positive group. In AQP-4 antibody positive patients, myelitis was most common presenting clinical feature followed by optic neuritis (ON), simultaneous ON with myelitis, and brainstem syndrome. In MOG antibody positive group, myelitis was the commonest phenotype followed by ON, brainstem syndrome, and cerebral syndrome. The neuroimaging revealed involvement of medulla mainly area postrema, cervicodorsal spinal cord and extension of cervical lesion up to brainstem more commonly in AQP4 antibody group, on the other hand involvement of upper brainstem (midbrain and pons), cortex, and conus was more common in MOG antibody group. CONCLUSION: We have made an attempt to find differentiating features in AQP-4 vs. MOG antibody positive cases but they were of no statistically significance value as the numbers were small. Further larger studies may prove helpful in planning better strategies in two groups.
format Online
Article
Text
id pubmed-9175426
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91754262022-06-09 Comparison of Clinical and Radiological Features of Aquaporin4 (AQP-4) Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) and Anti Myelin Oligodendrocyte Glycoprotein (Anti-MOG) Syndrome-Our Experience from Northwest India Jain, Rajendra Singh Jain, Deepak Murarka, Sourabh Vyas, Arvind Sharma, Bhawna Srivastava, Trilochan Kumar, Kamlesh Jain, Yavnika Rao, Kavya Agrawal, Jitesh Tejwani, Shankar Ann Indian Acad Neurol Original Article BACKGROUND: More and more cases of myelin oligodendrocyte glycoprotein (MOG) antibody are being diagnosed with the availability of laboratory tests helping us to know the differing patterns from AQP-4 antibody disease and we need to understand the natural course, treatment, and prognosis in a better way. OBJECTIVES: Neuromyelitis optica spectrum disorder (NMOSD) and anti-MOG syndromes are immune-mediated inflammatory demyelinating conditions of the central nervous system (CNS) that mainly involve the optic nerves and the spinal cord. We conducted this study to compare demographic, clinical, laboratory, and radiological features of AQP-4 antibody and MOG antibody positive patients. METHODS: A single-centre retrospective observational study from a large tertiary care university centre of Northwest India conducted during 2019--2021. We screened all patients presenting with acute CNS demyelinating attacks and recruited total 47 patients of which 25 were positive for AQP4 antibody and 22 were positive for MOG antibody. No patient tested positive for both antibodies. Data were collected using a standardized format including demographic, clinical, laboratory, and neuroimaging data. RESULTS: In our study, total 47 patients were included, amongst which 25 patients were AQP4 antibody and 22 patients were MOG antibody positive. Though there was no gender preponderance, pediatric patients were more frequently affected in MOG antibody positive group. In AQP-4 antibody positive patients, myelitis was most common presenting clinical feature followed by optic neuritis (ON), simultaneous ON with myelitis, and brainstem syndrome. In MOG antibody positive group, myelitis was the commonest phenotype followed by ON, brainstem syndrome, and cerebral syndrome. The neuroimaging revealed involvement of medulla mainly area postrema, cervicodorsal spinal cord and extension of cervical lesion up to brainstem more commonly in AQP4 antibody group, on the other hand involvement of upper brainstem (midbrain and pons), cortex, and conus was more common in MOG antibody group. CONCLUSION: We have made an attempt to find differentiating features in AQP-4 vs. MOG antibody positive cases but they were of no statistically significance value as the numbers were small. Further larger studies may prove helpful in planning better strategies in two groups. Wolters Kluwer - Medknow 2022 2022-02-07 /pmc/articles/PMC9175426/ /pubmed/35693673 http://dx.doi.org/10.4103/aian.aian_860_21 Text en Copyright: © 2006 - 2022 Annals of Indian Academy of Neurology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Jain, Rajendra Singh
Jain, Deepak
Murarka, Sourabh
Vyas, Arvind
Sharma, Bhawna
Srivastava, Trilochan
Kumar, Kamlesh
Jain, Yavnika
Rao, Kavya
Agrawal, Jitesh
Tejwani, Shankar
Comparison of Clinical and Radiological Features of Aquaporin4 (AQP-4) Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) and Anti Myelin Oligodendrocyte Glycoprotein (Anti-MOG) Syndrome-Our Experience from Northwest India
title Comparison of Clinical and Radiological Features of Aquaporin4 (AQP-4) Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) and Anti Myelin Oligodendrocyte Glycoprotein (Anti-MOG) Syndrome-Our Experience from Northwest India
title_full Comparison of Clinical and Radiological Features of Aquaporin4 (AQP-4) Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) and Anti Myelin Oligodendrocyte Glycoprotein (Anti-MOG) Syndrome-Our Experience from Northwest India
title_fullStr Comparison of Clinical and Radiological Features of Aquaporin4 (AQP-4) Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) and Anti Myelin Oligodendrocyte Glycoprotein (Anti-MOG) Syndrome-Our Experience from Northwest India
title_full_unstemmed Comparison of Clinical and Radiological Features of Aquaporin4 (AQP-4) Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) and Anti Myelin Oligodendrocyte Glycoprotein (Anti-MOG) Syndrome-Our Experience from Northwest India
title_short Comparison of Clinical and Radiological Features of Aquaporin4 (AQP-4) Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) and Anti Myelin Oligodendrocyte Glycoprotein (Anti-MOG) Syndrome-Our Experience from Northwest India
title_sort comparison of clinical and radiological features of aquaporin4 (aqp-4) antibody positive neuromyelitis optica spectrum disorder (nmosd) and anti myelin oligodendrocyte glycoprotein (anti-mog) syndrome-our experience from northwest india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175426/
https://www.ncbi.nlm.nih.gov/pubmed/35693673
http://dx.doi.org/10.4103/aian.aian_860_21
work_keys_str_mv AT jainrajendrasingh comparisonofclinicalandradiologicalfeaturesofaquaporin4aqp4antibodypositiveneuromyelitisopticaspectrumdisordernmosdandantimyelinoligodendrocyteglycoproteinantimogsyndromeourexperiencefromnorthwestindia
AT jaindeepak comparisonofclinicalandradiologicalfeaturesofaquaporin4aqp4antibodypositiveneuromyelitisopticaspectrumdisordernmosdandantimyelinoligodendrocyteglycoproteinantimogsyndromeourexperiencefromnorthwestindia
AT murarkasourabh comparisonofclinicalandradiologicalfeaturesofaquaporin4aqp4antibodypositiveneuromyelitisopticaspectrumdisordernmosdandantimyelinoligodendrocyteglycoproteinantimogsyndromeourexperiencefromnorthwestindia
AT vyasarvind comparisonofclinicalandradiologicalfeaturesofaquaporin4aqp4antibodypositiveneuromyelitisopticaspectrumdisordernmosdandantimyelinoligodendrocyteglycoproteinantimogsyndromeourexperiencefromnorthwestindia
AT sharmabhawna comparisonofclinicalandradiologicalfeaturesofaquaporin4aqp4antibodypositiveneuromyelitisopticaspectrumdisordernmosdandantimyelinoligodendrocyteglycoproteinantimogsyndromeourexperiencefromnorthwestindia
AT srivastavatrilochan comparisonofclinicalandradiologicalfeaturesofaquaporin4aqp4antibodypositiveneuromyelitisopticaspectrumdisordernmosdandantimyelinoligodendrocyteglycoproteinantimogsyndromeourexperiencefromnorthwestindia
AT kumarkamlesh comparisonofclinicalandradiologicalfeaturesofaquaporin4aqp4antibodypositiveneuromyelitisopticaspectrumdisordernmosdandantimyelinoligodendrocyteglycoproteinantimogsyndromeourexperiencefromnorthwestindia
AT jainyavnika comparisonofclinicalandradiologicalfeaturesofaquaporin4aqp4antibodypositiveneuromyelitisopticaspectrumdisordernmosdandantimyelinoligodendrocyteglycoproteinantimogsyndromeourexperiencefromnorthwestindia
AT raokavya comparisonofclinicalandradiologicalfeaturesofaquaporin4aqp4antibodypositiveneuromyelitisopticaspectrumdisordernmosdandantimyelinoligodendrocyteglycoproteinantimogsyndromeourexperiencefromnorthwestindia
AT agrawaljitesh comparisonofclinicalandradiologicalfeaturesofaquaporin4aqp4antibodypositiveneuromyelitisopticaspectrumdisordernmosdandantimyelinoligodendrocyteglycoproteinantimogsyndromeourexperiencefromnorthwestindia
AT tejwanishankar comparisonofclinicalandradiologicalfeaturesofaquaporin4aqp4antibodypositiveneuromyelitisopticaspectrumdisordernmosdandantimyelinoligodendrocyteglycoproteinantimogsyndromeourexperiencefromnorthwestindia